Hugo Acurio AI in pharmacovigilance in Latin America: what ARCSA, ANVISA and COFEPRIS expect The short answer None of the three regulators has written an AI rule for pharmacovigilance yet. What they specify is the case record, and Ecuador and Brazil have done it recently and in detail: E2B(R3... Oct 8, 2026
Hugo Acurio AI regulatory compliance for healthcare and pharma operations The short answer I build AI for regulated healthcare and pharma that runs in production and leaves a record an auditor can trace. My rule: the AI prepares and suggests, a human decides, and every step... Oct 8, 2026
Hugo Acurio Black Box on the Inside. Glass Box on the Record. The short answer I'm Hugo Acurio, and I designed and built Iris Global Ecuador's pharmacovigilance system ahead of ARCSA's new standard, which takes full effect November 4, 2026. It's a regional platf... Oct 5, 2026 Case studies
Hugo Acurio The Visible Margin Lies. The short answer I'm Hugo Acurio, and I killed Iris Global Ecuador's first product launch before it drained the company, once I found that a 30% gross margin on paper went to zero after the government... Oct 5, 2026 Case studies
Hugo Acurio What should a healthcare company hire for in a Fractional Chief AI Officer? The short answer Hire for AI that already runs in production inside a regulated P&L. A model-building résumé is the wrong filter. Only about 5% of organizations get generative AI into production with ... Oct 5, 2026
Hugo Acurio Slop Wars: the slop was already there Thinking The selective amnesia on LinkedIn dumbfounds me. AI slop sucks? Sure. But apparently in a galaxy far, far away (before ChatGPT) nobody ever wrote garbage — we all lived in a world full of tho... Thinking Sep 23, 2026
Hugo Acurio Bogotá · Seton Hall Law LATAM-HCCP 2026 Field note 📍 Seton Hall Law's LATAM Healthcare Compliance Certificate Program. Bogotá. I made an unpopular case: The reform wave hitting Latin America — ANVISA VigiMed, ARCSA's new standard, COFEPRIS'... Field notes Sep 21, 2026
Hugo Acurio How to Give an AI Agent Memory Without Breaking the Audit Trail Every team that builds an AI agent eventually hits the same wall. The agent is sharp inside a single conversation, then the conversation ends and it forgets everything. So someone says "let's give it ... Jul 31, 2026
Hugo Acurio The F1 Business Era I have spent fifteen years running operations in consumer health, telehealth, and pharma. The most useful number I ever watched was never in a monthly report. It was the signal that moved before the r... Jul 29, 2026
Hugo Acurio The regulated operating system, built from zero The board I saw A founder-led pharma and diagnostics business has a particular problem that does not announce itself early. The commercial side can work (product moves, customers order, revenue arrive... Jul 20, 2026 Case studies
Hugo Acurio An AI Sales Agent on a Live Channel: The Guardrails Are the Product The short answer In 13 days, I (Hugo Acurio) put a production AI sales agent on a live, regulated WhatsApp channel, and it recovered ~45% of warm leads that were going cold overnight. It holds up beca... Jul 5, 2026 Case studies
Hugo Acurio Multidimensional Omron LATAM Expansion The board I saw Omron had category-leading products and a genuine opportunity across Latin America, and no go-to-market machine built for the region's specific gaps. Distribution did not exist at the ... Jul 5, 2026 Case studies